ipscell.com
New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research - The Niche
It’s been a seemingly rather quiet year on the regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank the … New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »
Professor Paul Knoepfler, Ph.D.